Fine Foods & Pharmaceuticals NTM SpA
MIL:FF

Watchlist Manager
Fine Foods & Pharmaceuticals NTM SpA Logo
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Watchlist
Price: 7.44 EUR 0.81% Market Closed
Market Cap: 182.2m EUR
Have any thoughts about
Fine Foods & Pharmaceuticals NTM SpA?
Write Note

Gross Margin
Fine Foods & Pharmaceuticals NTM SpA

30.7%
Current
28%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.7%
=
Gross Profit
112.5m
/
Revenue
367.1m

Gross Margin Across Competitors

Country IT
Market Cap 182.1m EUR
Gross Margin
31%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 201.6B USD
Gross Margin
41%
Country US
Market Cap 167B USD
Gross Margin
60%
Country KR
Market Cap 65.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.7B USD
Gross Margin
55%
Country US
Market Cap 36.4B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24.2B USD
Gross Margin
35%
Country US
Market Cap 22.4B USD
Gross Margin
60%
No Stocks Found

Fine Foods & Pharmaceuticals NTM SpA
Glance View

Market Cap
182.1m EUR
Industry
Life Sciences Tools & Services

Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 768 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

FF Intrinsic Value
17.32 EUR
Undervaluation 57%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.7%
=
Gross Profit
112.5m
/
Revenue
367.1m
What is the Gross Margin of Fine Foods & Pharmaceuticals NTM SpA?

Based on Fine Foods & Pharmaceuticals NTM SpA's most recent financial statements, the company has Gross Margin of 30.7%.